ReviewZeitschrift fur Gastroenterologie2025

From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis.

Elisabeth Schnoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.